相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non-Hodgkin lymphoma
Shazia Nakhoda et al.
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy
Lindsey E. Roeker et al.
DRUGS (2022)
Real-world management of targeted therapies in chronic lymphocytic leukemia
Taylor M. Weis et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2022)
Bruton's Kinase Inhibitors for the Treatment of Immunological Diseases: Current Status and Perspectives
Ewa Robak et al.
JOURNAL OF CLINICAL MEDICINE (2022)
The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030
Mengbao Du et al.
JOURNAL OF ONCOLOGY (2022)
Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
Constantine S. Tam et al.
LANCET ONCOLOGY (2022)
Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE)
Maggie Czarnogorski et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2022)
Zanubrutinib in Combination with Venetoclax for Patients with Treatment-Naive (TN) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) with del(17p): Early Results from Arm D of the SEQUOIA (BGB-3111-304) Trial
Alessandra Tedeschi et al.
BLOOD (2021)
Current and emerging investigational venetoclax-based therapies in chronic lymphocytic leukemia
Stefano Molica et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice
Susan M. O'Brien et al.
FRONTIERS IN ONCOLOGY (2021)
Crosstalk between Noxa, Bcl-2, and ceramide in mediating p53-dependent apoptosis in Molt-4 human T-cell leukemia
Hadile Kobeissy et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound-The Venetoclax Story
Arian Emami Riedmaier et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma
John C. Kraft et al.
AIDS (2017)
Evolutionary dynamics of cancer in response to targeted combination therapy
Ivana Bozic et al.
ELIFE (2013)
Gene expression analysis of 1,25(OH)2D3-dependent differentiation of HL-60 cells:: a cDNA array study
H Savli et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells
ZN Ji et al.
PLANTA MEDICA (2002)